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Editorial
H1N1 2009 in Karachi: A situational analysis
Bushra Jamil, Syed Faisal Mahmood

Department of Medicine, Aga Khan University Hospital, Karachi.

The novel H1N1 influenza A, also known as Swine
Flu, first emerged in Mexico in March 2009, when the
Government of Mexico reported increasing cases of
Influenza-Like Illness (ILI).1,2 By April, more than 854 cases
of pneumonia with 59 deaths were recorded. On the 24th of
April 2009, the United States Government reported seven
human cases of what was thought to be Swine Influenza in
California. Twelve of the 18 laboratory confirmed Mexican
cases were found to be genetically identical to this virus,1
which emerged as a consequence of a series of viral
coinfections in pigs leading to gene reassortment between
human, avian and two strains of swine influenza A viruses.3 As
opposed to the seasonal H1N1, this novel influenza virus was
unique not only in the continent of origin (North America, not
Asia), the season of origin (spring, not late fall), but also the
cohort at risk for infection and death (children and young
adults, not infants and the elderly).4 Moreover, this virus had
not been previously detected in animals or humans and the
geographical spread of multiple community outbreaks along
with the somewhat unusual age groups affected, all portended
a pandemic. As the infection spread, however, it became
apparent that the virus was in actuality a new strain of the
human influenza virus and not a swine influenza virus and the
name was changed to 2009 Pandemic influenza A H1N1 virus
or simply 2009 H1N1 Influenza virus.5
As predicted, the number of cases and the number of
countries affected rose sharply and by July 2009, the WHO
officially declared that the world was in the midst of a novel
H1N1 influenza pandemic. Since then there have been more
than 622482 cases as of November 2009 and 13554 deaths as
of January 2010. However, as a number of regions have
stopped reporting the number of cases and deaths, the actual
numbers are likely to far exceed these estimates. In countries
where outbreaks have occurred, obesity and pregnancy6,7 have
been reported as risk factors for admission to an intensive care
unit (ICU). Diarrhoea has been documented in up to 20% and
fever in up to 85% of inpatients. However, fever was absent in
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as many as 50% of outpatients and nearly three quarters of the
patients had one or more underlying medical conditions.6

Karachi saw its first four confirmed cases of novel
H1N1 in June 2009. All four were young individuals in their
teens and had a history of recent travel to the US, where they
developed ILI. The symptoms were mild and they recovered
without antiviral treatment. Between June and November,
there was only one more case of laboratory confirmed novel
H1N1 influenza A. Similar to the prior cases, this 63 year old
gentleman, who had presented in August, also had a history of
recent travel (this time to Singapore). He made a full recovery
after 5 days of Oseltamivir. In early October and November,
the number of ILI cases rose suddenly. The symptoms of
myalgia, sore throat, non-productive cough, fever chills,
headache and fatigue were non-specific and clinically
indistinguishable from the ongoing seasonal Dengue fever
outbreak, which was one reason for delays in diagnosis.
Similarly, as reported from other affected countries,8 as
opposed to the seasonal influenza, vomiting and diarrhoea was
also noted to be a common feature in our patients. Other signs
of increased influenza activity in the community were also
present including an increase in the number of Emergency
Room visits with respiratory complaints as well as an increase
in the number of admissions due to severe respiratory disease.
Most of these patients were not tested for the novel H1N1,
however, in a cluster of individuals (total number in excess of
50) 12 could be tested and 6 were confirmed positive with
H1N1. Following this, in December, the number of cases
reported by the laboratory at the Aga Khan University
Hospital increased dramatically. Interestingly, this occurred
almost immediately after the lay press reported that H1N1
cases were on the rise in Karachi. Hence this increase may
actually represent better case detection due to increased
awareness, as opposed to an actual rise in the number of
individuals infected in the city. Nonetheless, the numbers of
ILI cases have continued to increase and by the end of
January, 2010 those which have tested positive for H1N1
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stand in excess of 80 in Karachi alone.

It is important to note that laboratory diagnosis
depends on nucleic acid amplification of H1N1 virus through
real time reverse transcriptase polymerase chain reaction (rRTPCR)9 which is available at two centers in the country: NIH
Islamabad and the Aga Khan University Hospital, Karachi.
However, most patients with clinical illness consistent with
uncomplicated influenza who reside in an area where
influenza viruses are circulating do not require diagnostic
influenza testing for clinical management. Only patients who
are hospitalized with suspected H1N1 infection or in whom a
diagnosis of influenza will modify decisions regarding clinical
care (for example in individuals at risk of developing severe
disease such as pregnant women, children less than 2 years or
those with chronic medical problems) need to be tested.9
Therefore, the number of patients infected with H1N1 flu
reported by the press is subject to a severe selection bias as
most cases are mild and go undetected.

Most cases of ILI in Karachi (proven to be H1N1 or
otherwise) have been mild and self limiting. While a total of 7
deaths (personal communication, Sindh focal person for swine
flu) have been reported from Karachi alone, in the absence of
an accurate denominator (i.e. the total number of infected),
estimating mortality rates is impossible. According to a press
release10 the official figure of confirmed H1N1 cases for
Pakistan stands at 168 out of total 650 suspected cases, which
were tested at National Institute of Health (NIH) Islamabad
with 14 deaths. This figure does not take into account 80
confirmed cases and 7 deaths from Karachi.

Under the current circumstances, mortality data, not
only from Pakistan but also from other parts of the world
should be viewed with caution. When testing confirms H1N1
infection in patients with underlying medical conditions,
many doctors record these deaths as due to the medical
condition, and not to the pandemic virus. These cases are also
missed in official statistics. Moreover, in Pakistan and also in
a large number of other developing countries, most deaths are
neither investigated nor certified in terms of the cause.11
Finally, accurate test results will also depend on availability,
cost and how and when samples were taken. These factors
coupled with the lack of a national Flu surveillance system
makes it unlikely that accurate figures regarding the burden of
H1N1 and the mortality rate from H1N1 in Pakistan will be
forthcoming. When we look at other countries, the overall
estimated case fatality rate in the UK has been 26 (range 1166) per 100 00012 and in the US, 20 per 100 000.13
The antiviral agents which are effective against the
current H1N1 pandemic strain such as Oseltamivir and
Zanamivir may be partly responsible for these low rates.
However, viewed statistically, mortality in this pandemic
compares favourably with 20th century influenza pandemics
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and for the most part the infection seems to be mild.6
Treatment for most cases is therefore not recommended and is
limited only to those with severe disease or those who are at
risk of developing severe disease (see above). When a
decision is made to use antiviral treatment for influenza,
however, it should be initiated as soon as possible and without
waiting for test results as antiviral treatment is most effective
when administered within 48 hours of onset of symptoms.14
However, studies have shown that hospitalized patients still
benefit when treatment is started with Oseltamivir more than
48 hours after the onset of illness.15 These recommendations
have recently been questioned. A team of Cochrane reviewers
surveyed the literature on efficacy of Oseltamivir and
Zanamivir and from 8 acceptable prophylaxis trials and 12
acceptable treatment trials found that for pre- or postexposure
prophylaxis against influenza, both drugs were mildly
effective. For treatment, both drugs shortened duration of
symptomatic influenza by 12 to 24 hours if taken early in
infection. The reviewers reported difficulty in evaluating the
data supporting Oseltamivir's claimed ability to prevent
complications of influenza.16

Globally, questions have been raised about how severe
the pandemic would be and whether hospitals would have
sufficient surge capacity. This is an important consideration
for hospitals in Pakistan, since we are in the middle of an
outbreak and no one should be complacent about an
unpredictable virus which is capable of killing children and
young adults in their prime.4 A lower population impact than
previous pandemics, however, is not a justification for public
health intraction. With the influenza H1N1 2009 pandemic
finally here, the only reliable means of preventing infection is
the vaccine. This unfortunately remains in short supply and is
not expected to become available in Pakistan before the end of
January 2010 (or later). Once this arrives, priority should be
given to high risk groups only (i.e. health care workers,
pregnant women, immunocompromised individuals, and
young children. Adherence to Infection Control practices in
the hospital is paramount and depends heavily on respiratory
etiquette, hand hygiene, and avoiding close contact with sick
people. People with ILI should be instructed to keep their
hands clean and stay at home for at least 24 hours after
resolution of fever and should stay away from people at high
risk for severe infection, e.g. pregnant women, young
children, those with chronic medical conditions and
suppressed immunity.
As clinicians, the onus therefore falls on us to help our
patients comprehend the often sensationalized news in the lay
press regarding H1N1 by emphasizing the relatively mild
nature of the disease in most individuals and the limited need
for testing and treatment. As always, simple precautions both
in the hospital and home will suffice in preventing this
infection from spreading further.
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